Noticias y vídeos - CHECK-CAP

Check-Cap Regains Compliance With Nasdaq Minimum Bid Price Requirement PR Newswire ISFIYA, Israel, April 19, 2018 ISFIYA, Israel , April 19, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has received notification from the Listing Qualifications Department of The Nasdaq...

Check-Cap Files Annual Report for the Year Ended December 31, 2017 PR Newswire ISFIYA, Israel, April 5, 2018 ISFIYA, Israel , April 5, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company developing a capsule-based system for preparation-free, colorectal cancer screening, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2017 with the U.S. Securities and...

Check-Cap Reports Fourth Quarter and Full Year 2017 Financial Results Announces the achievement of key validation milestones in C-Scan® system clinical and regulatory pathway PR Newswire ISFIYA, Israel, April 4, 2018 ISFIYA, Israel , April 4, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company developing a capsule-based system for preparation-free, colorectal cancer screening, today provided a corporate update...

Check-Cap Initiates EU Post Approval Study Using Advanced C-Scan® Advanced C-Scan Demonstrated Significant Improvement in Average Colon Imaging Coverage in Interim Clinical Evaluation PR Newswire ISFIYA, Israel, March 12, 2018 ISFIYA, Israel , March 12, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer...

Check-Cap Appoints Alex Ovadia as Chief Executive Officer Global Operations and R&D Veteran Brings Focus to C-Scan® Commercial Pathway PR Newswire ISFIYA, Israel, Feb. 26, 2018 ISFIYA, Israel , Feb. 26, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced the appointment of Alex Ovadia...

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire ISFIYA, Israel and BOSTON, Jan. 19, 2018 ISFIYA, Israel and BOSTON , Jan. 19, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced that the Company received a letter from Nasdaq (the "Letter"), indicating...

Check-Cap Receives CE Mark Approval for C-Scan® PR Newswire ISFIYA, Israel and BOSTON, Jan.10, 2018 ISFIYA, Israel and BOSTON , Jan.10, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced it has received CE Mark approval for the C-Scan system. The C-Scan system offers an...

Check-Cap Announces Advancement in GE Healthcare Manufacturing Collaboration New Phase Supports C-Scan® Assembly, Testing & Distribution Initially for US Pilot Trial PR Newswire ISFIYA, Israel and BOSTON, Dec. 5, 2017 ISFIYA, Israel and BOSTON , Dec. 5, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan ® , an ingestible capsule for preparation-free, colorectal cancer...

Check-Cap Ltd. Announces Closing of $2.5 Million Registered Direct Offering PR Newswire ISFIYA, Israel and BOSTON, Nov. 22, 2017 ISFIYA, Israel and BOSTON , Nov. 22, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced the closing of its previously announced registered direct offering with certain...

Check-Cap Ltd. Announces $2.5 Million Registered Direct Offering PR Newswire ISFIYA, Israel and BOSTON, Nov. 20, 2017 ISFIYA, Israel and BOSTON , Nov. 20, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has entered into definitive agreements with institutional investors for the...

Check-Cap Reports Third Quarter 2017 Financial Results PR Newswire ISFIYA, Israel and BOSTON, Nov. 6, 2017 ISFIYA, Israel and BOSTON , Nov. 6, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced its financial results for the third quarter and nine months ended September 30, 2017 . Recent...

Check-Cap Announces Acceptance of Late Breaking Clinical Performance Abstract at United European Gastroenterology Week 2017 PR Newswire ISFIYA, Israel and BOSTON, Oct. 24, 2017 ISFIYA, Israel and BOSTON , Oct. 24, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan ® , an ingestible capsule for preparation-free, colorectal cancer screening, today announced the acceptance of an...

Check-Cap Announces Filing of CE Mark Registration for C-Scan® Management Hosts Conference call at 9:00 a.m. EDT PR Newswire ISFIYA, Israel and BOSTON, Sept. 27, 2017 ISFIYA, Israel and BOSTON , Sept. 27, 2017 /PRNewswire/ --Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan ® , an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has filed...

Check-Cap Reports Second Quarter 2017 Financial Results PR Newswire ISFIYA, Israel and BOSTON, Aug. 10, 2017 ISFIYA, Israel and BOSTON , Aug. 10, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the second quarter and six...

Check-Cap Ltd. Announces Closing of $2.69 Million Financing PR Newswire ISFIYA, Israel and BOSTON, June 2, 2017 ISFIYA, Israel and BOSTON , June 2, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced the closing of the previously announced definitive agreement with a single health-care focused...

Check-Cap Ltd. Announces $2.69 Million Financing PR Newswire ISFIYA, Israel and BOSTON, May 30, 2017 ISFIYA, Israel and BOSTON , May 30, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has entered into a definitive agreement with a single health-care focused institutional investor for...

Check-Cap Reports First Quarter 2017 Financial Results PR Newswire ISFIYA, Israel, May 9, 2017 ISFIYA, Israel , May 9, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan ® , an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the three months ended March 31, 2017 ....

Check-Cap and GE Healthcare Achieve Development Milestone in High-volume X-Ray Capsule Manufacturing Collaboration Ingestible capsule brings patients one step closer to prep-free, colon screening PR Newswire ISFIYA, Israel and CHALFONT ST. GILES, England, May 9, 2017 ISFIYA, Israel and CHALFONT ST. GILES, England , May 9, 2017 /PRNewswire/ -- Check-Cap Ltd. (NASDAQ: CHEK, CHEKW), a clinical-stage company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer...

Check-Cap Reports Fourth Quarter and Fiscal Year 2016 Financial Results PR Newswire ISFIYA, Israel, March 9, 2017 ISFIYA, Israel , March 9, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the fourth quarter and fiscal year ended...

Check-Cap Ltd. to Webcast, Live, at VirtualInvestorConferences.com on Thursday, February 2 PR Newswire ISFIYA, Israel and BOSTON, Jan. 30, 2017 Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com ISFIYA, Israel and BOSTON , Jan. 30, 2017 /PRNewswire/ -- Check-Cap Ltd. (NASDAQ: CHEK), engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening today announced...